Did Johnson & Johnson Just Spit in Alphabet's Face?

If you had any doubts whether or not Johnson & Johnson (NYSE: JNJ) is serious about robotic surgery, you now have your answer. The healthcare giant announced on Wednesday that it plans to acquire privately held robotic surgery company Auris Health for $3.4 billion.